Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tumor cell autocrine motility factor.

L A Liotta, R Mandler, G Murano

    Proceedings of the National Academy of Sciences of the United States of America
    |May 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Declines in Pregnancies among U.S. Adolescents from 2007 to 2017: Behavioral Contributors to the Trend.

    Journal of pediatric and adolescent gynecology·2022
    Same author

    2013 SYR Accepted Poster Abstracts.

    International journal of yoga therapy·2013
    Same author

    Peripheral and central nervous system inhibition of 11β-hydroxysteroid dehydrogenase type 1 in man by the novel inhibitor ABT-384.

    Translational psychiatry·2013
    Same author

    HMGB1 mediates splenomegaly and expansion of splenic CD11b+ Ly-6C(high) inflammatory monocytes in murine sepsis survivors.

    Journal of internal medicine·2013
    Same author

    Association of dopamine-related genetic loci to dopamine D3 receptor antagonist ABT-925 clinical response.

    Translational psychiatry·2013
    Same author

    About stibio-intolerance and stibio-resistance in the treatment of internal leishmaniasis.

    Il Progresso medico·2010

    Researchers isolated a novel protein, autocrine motility factor (AMF), from melanoma cells. This factor stimulates tumor cell motility and may play a key role in cancer cell invasion.

    Area of Science:

    • Cell Biology
    • Biochemistry
    • Oncology

    Background:

    • Tumor cell invasion is a critical determinant of cancer metastasis.
    • Understanding the molecular mechanisms that drive cell motility is essential for developing targeted therapies.

    Purpose of the Study:

    • To isolate and characterize a novel factor that stimulates melanoma cell motility.
    • To investigate the potential role of this factor in tumor cell invasion and metastasis.

    Main Methods:

    • Isolation and purification of the motility-stimulating factor from human A2058 melanoma cell conditioned medium.
    • Protein characterization including size estimation and amino acid analysis.
    • Functional assays to assess the effect of the factor on cell motility and phospholipid methylation.

    Related Experiment Videos

  • Analysis of factor production in ras oncogene-transfected NIH 3T3 cells.

    • Main Results:

    • A 55 kDa protein, termed autocrine motility factor (AMF), was isolated and purified.
    • AMF significantly stimulated random and directed motility of melanoma cells at low concentrations.
    • AMF enhanced the methylation of phosphatidyldimethylethanolamine to phosphatidylcholine in cell membranes.
    • AMF was highly produced by metastatic NIH 3T3 cells transfected with the ras oncogene.

    Conclusions:

    • Autocrine motility factor (AMF) is a novel protein that enhances tumor cell motility.
    • AMF may contribute to the local invasion and metastasis of cancer cells.
    • Further research into AMF could lead to new therapeutic strategies for cancer treatment.